![71074-44-7 | Methotrexate Dimethylamide (>90%) | N2-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-N,N-dimethyl-L-glutamine; NSC 281286 | C₂₂H₂₇N₉O₄ | TRC 71074-44-7 | Methotrexate Dimethylamide (>90%) | N2-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-N,N-dimethyl-L-glutamine; NSC 281286 | C₂₂H₂₇N₉O₄ | TRC](https://www.trc-canada.com/prod-img/M260695.png)
71074-44-7 | Methotrexate Dimethylamide (>90%) | N2-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-N,N-dimethyl-L-glutamine; NSC 281286 | C₂₂H₂₇N₉O₄ | TRC
![Pharmaceuticals | Free Full-Text | Protective Effect of Pycnogenol against Methotrexate-Induced Hepatic, Renal, and Cardiac Toxicity: An In Vivo Study Pharmaceuticals | Free Full-Text | Protective Effect of Pycnogenol against Methotrexate-Induced Hepatic, Renal, and Cardiac Toxicity: An In Vivo Study](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-15-00674/article_deploy/html/images/pharmaceuticals-15-00674-g001.png)
Pharmaceuticals | Free Full-Text | Protective Effect of Pycnogenol against Methotrexate-Induced Hepatic, Renal, and Cardiac Toxicity: An In Vivo Study
![51865-79-3 | (R)-Methotrexate | D-Amethopterin; D-Methotrexate; N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-D-glutamic Acid; | C₂₀H₂₂N₈O₅ | TRC 51865-79-3 | (R)-Methotrexate | D-Amethopterin; D-Methotrexate; N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-D-glutamic Acid; | C₂₀H₂₂N₈O₅ | TRC](https://www.trc-canada.com/prod-img/M260665.png)